{
  "chunk_id": "VIII_i_1_B_12",
  "content": "/>\nVIII.i.1.B.1.g\n.\nDate Disabilities Became Subject to Presumptive SC Under 38 CFR 3.309(e)\nThe table below shows the dates on which the diseases listed in\n38 CFR 3.309(e)\nbecame subject to presumptive SC.\nDisability\nEffective Date\nChloracne or other acne-form disease consistent with chloracne, and\nsoft-tissue sarcoma,\nother than\nosteosarcoma\nchondrosarcoma\nKaposi’s sarcoma, or\nmesothelioma\nFebruary 6, 1991\nNote\n:  Originally, September 25, 1985, under 38 CFR 3.311a.\nNon-Hodgkin’s lymphoma (NHL)\nFebruary 6, 1991\nNote\n:  Originally, August 5, 1964, under 38 CFR 3.313.\nPCT, and\nHodgkin’s disease\nFebruary 3, 1994\nRespiratory cancers of the\nlung\nbronchus\nlarynx, or\ntrachea, and\nmultiple myeloma\nJune 9, 1994\nProstate cancer, and\nacute and subacute peripheral neuropathy\nNovember 7, 1996\nType 2 diabetes mellitus\nMay 8, 2001\nChronic lymphocytic leukemia (CLL)\nOctober 16, 2003\nAL amyloidosis\nMay 7, 2009\nIschemic heart disease (IHD)\nchronic B-cell leukemia, and\nParkinson’s disease\nAugust 31, 2010\nEarly-onset peripheral neuropathy\nSeptember 6, 2013\nParkinsonism\nbladder cancer, and\nhypothyroidism.\nReference\n:  For more information on presumptive SC for these disabilities, see\nPL 116-283\n,\nWilliam M. (Mac) Thornberry National Defense Authorization Act for Fiscal Year 2021\n, and\nVeterans Benefits Administration (VBA) Letter 20-21-07, Processing Guidance for Claims and Appeals for New Agent Orange Presumptive Conditions\n.\nJanuary 1, 2021\nmonoclonal gammopathy of undetermined significance, and\nhypertension\nReference\n:  For more information on processing claims for these disabilities, see the\nPACT Act Implementation SOP\n.\nAugust 10, 2022\nImportant\n:  The table above includes reference to acute and subacute peripheral neuropathy becoming subject to presumptive SC on November 7, 1996, for historical purposes. The covered disease was revised to early-onset peripheral neuropathy by change effective September 6, 2013.  For claims on or after September 6, 2013, entitlement to presumptive SC based on peripheral neuropathy only exists when the Veteran meets qualifying service requirements specified at\nM21-1, Part VIII, Subpart i, 1.B.1.c\nand medical evidence establishes a confirmed diagnosis of early-onset peripheral neuropathy.\nNote\n:  Unless an earlier effective date is determined pursuant to the\nNehmer\nstipulation under\n38 CFR 3.816\n, the provisions pertaining to retroactive payment under\n38 CFR 3.114(a)\napply.\nReference\n:  For more information on the\nNehmer\nstipulation, see\n38 CFR 3.816\nM21-1, Part VIII, Subpart i, 2.B\n, and\nthe\nNehmer Training Guide\n.",
  "title": "M21-1, Part VIII, Subpart i, Chapter 1, Section B - Ratings for Disabilities Associated with Herbicide Exposure",
  "citation": "Part VIII, Subpart i, Chapter 1, Section B",
  "source_url": "https://www.knowva.ebenefits.va.gov/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000177423/M21-1-Part-VIII-Subpart-i-Chapter-1-Section-B-Ratings-for-Disabilities-Associated-with-Herbicide-Exposure",
  "updated": "",
  "scraped_at": "2025-06-16T22:55:03.922665",
  "tags": [
    "m21-1"
  ]
}